GC-Rise Pharmaceutical develops and commercializes medical products for women and children in China and offers services to international partners including local registration, clinical trials, pricing, distribution, market promotion, brand-building and patient education. The company leverages experience in clinical development, clinical trials and registration in China alongside a commercial distribution and hospital sales force. It is led by CEO Wren Zhang and was founded in 2008 in Beijing. GC-Rise’s sales force covers over 1,000 hospitals in major Chinese cities and distributes products to 10,000 drug stores. The company plans to use new funding to strengthen commercialization capabilities, expand its product portfolio and build an online-to-offline (O2O) platform dedicated to women and children’s healthcare. The company’s combination of regulatory, clinical and commercial capabilities supports its go-to-market and partnership services.

Total raised

$15M

Funding rounds

1

Latest round

Series B

Latest activity

Sep 2014